Michael Tillinger

Papers

1

Total Citations

8

H-Index

1

About

Dr. Michael Tillinger is a pioneering urologic surgeon whose research focuses on advanced reconstructive techniques for complex bladder conditions, particularly neurogenic bladder and complications arising from pelvic surgery. His most notable contribution is the development and clinical investigation of the Tengion Autologous Neo-Bladder Augment™ (NBA), a groundbreaking tissue-engineered construct designed for augmentation cystoplasty in patients with neurogenic bladder secondary to spina bifida. This Phase 2 study, which has garnered 8 citations, represents a significant leap toward regenerative medicine solutions in urology, offering an alternative to traditional bowel-based augmentation. Dr. Tillinger has also made important contributions to the management of rectovesical fistula (RVF), a rare but severe complication of radical prostatectomy, providing clinical insights into surgical repair strategies following recognized rectal injury. His work bridges the gap between innovative tissue engineering and practical surgical outcomes, addressing some of the most challenging cases in reconstructive urology. Through his research, Dr. Tillinger continues to advance the field by exploring regenerative approaches that could transform the standard of care for patients with congenital and acquired bladder dysfunction.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
A PHASE 2 STUDY - TENGION AUTOLOGOUS NEO-BLADDER AUGMENT™ (NBA) FOR AUGMENTATION CYSTOPLASTY IN SUBJECTS WITH NEUROGENIC BLADDER SECONDARY TO SPINA BIFIDA
8 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 6

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago